Kairos Pharma, LTD. insider trading activity

Understanding Insider Activity at Kairos Pharma, LTD.

Welcome to our dedicated page for Kairos Pharma, LTD. (: KAPA) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Kairos Pharma, LTD.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Kairos Pharma, LTD., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for KAPA
TickerTime & DateFilingLink
KAPA01:30:12 AM, 11/26/2024
Murali Ramachandran(VP of Research and Development) purchased 200 shares of Kairos Pharma, LTD. (KAPA) for ~$318
Filing
KAPA11:03:39 AM, 11/25/2024
Samuelson Doug(Chief Financial Officer) purchased 2500 shares of Kairos Pharma, LTD. (KAPA) for ~$3750
Filing
KAPA02:53:44 AM, 11/22/2024
Yu John S(CEO and Chairman) purchased 4000 shares of Kairos Pharma, LTD. (KAPA) for ~$5760
Filing